Gynaecological Cancers Group, QIMR Berghofer Medical Research Institute, Brisbane, Australia; Faculty of Medicine, The University of Queensland, Herston Road, Brisbane, Queensland, Australia.
Gynaecological Oncology Research Group, Division of Cancer Sciences, University of Manchester, St Mary's Hospital, Oxford Road, Manchester, United Kingdom; Department of Obstetrics and Gynaecology, Manchester University NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, United Kingdom.
Gynecol Oncol. 2018 Jul;150(1):99-105. doi: 10.1016/j.ygyno.2018.04.006. Epub 2018 Apr 26.
Although endometrial cancer (EC) is associated with relatively good survival rates overall, women diagnosed with high-risk subtypes have poor outcomes. We examined the relationship between lifestyle factors and subsequent all-cause, cancer-specific and non-cancer related survival.
In a cohort of 1359 Australian women diagnosed with incident EC between 2005 and 2007 pre-diagnostic information was collected by interview at recruitment. Clinical and survival information was abstracted from women's medical records, supplemented by linkage to the Australian National Death Index. Cox proportional hazards regression was used to estimate hazard ratios (HRs) and 95% confidence intervals (CIs) for all-cause and cause-specific survival (EC death vs. non-EC death) associated with each exposure, overall and by risk group (low-grade endometrioid vs. high-grade endometrioid and non-endometrioid).
After a median follow-up of 7.1 years, 179 (13%) women had died, with 123 (69%) deaths from EC. As expected, elevated body mass index (BMI), diabetes and the presence of other co-morbidities were associated with a significantly increased risk of all-cause and non-cancer related death. Women with diabetes had higher cancer-specific mortality rates (HR 2.09, 95% CI 1.31-3.35), particularly those who had were not obese (HR 4.13, 95% CI 2.20-7.76). The presence of ≥2 other co-morbidities (excluding diabetes) was also associated with increased risk of cancer-specific mortality (HR 3.09, 95% CI 1.21-7.89). The patterns were generally similar for women with low-grade and high-grade endometrioid/non-endometrioid EC.
Our findings demonstrate the importance of diabetes, other co-morbidities and obesity as negative predictors of mortality among women with EC but that the risks differ for cancer-specific and non-cancer related mortality.
尽管子宫内膜癌(EC)总体上的存活率相对较高,但被诊断为高危亚型的女性预后较差。我们研究了生活方式因素与全因、癌症特异性和非癌症相关生存之间的关系。
在 2005 年至 2007 年间确诊为 EC 的 1359 名澳大利亚女性的队列中,在招募时通过访谈收集了发病前的信息。从女性的病历中提取临床和生存信息,并通过与澳大利亚国家死亡指数的链接进行补充。使用 Cox 比例风险回归估计了与每种暴露相关的全因和癌症特异性生存(EC 死亡与非 EC 死亡)的风险比(HR)和 95%置信区间(CI),总体上以及按风险组(低级别子宫内膜样癌与高级别子宫内膜样癌和非子宫内膜样癌)进行分层。
中位随访 7.1 年后,179 名(13%)女性死亡,其中 123 名(69%)死于 EC。如预期的那样,较高的体重指数(BMI)、糖尿病和其他合并症的存在与全因和非癌症相关死亡的风险显著增加相关。患有糖尿病的女性癌症特异性死亡率更高(HR 2.09,95%CI 1.31-3.35),尤其是那些不肥胖的女性(HR 4.13,95%CI 2.20-7.76)。存在≥2 种其他合并症(不包括糖尿病)也与癌症特异性死亡率增加相关(HR 3.09,95%CI 1.21-7.89)。对于低级别和高级别子宫内膜样癌/非子宫内膜样癌的女性,这些模式大致相似。
我们的研究结果表明,糖尿病、其他合并症和肥胖是 EC 女性死亡率的负面预测因素,但癌症特异性和非癌症相关死亡率的风险不同。